Healthcare Industry News: saphenous vein
News Release - April 18, 2006
Sciton Introduces Pro-V(TM) for Endovenous Laser Treatment of the Great Saphenous VeinPALO ALTO, Calif., April 18 (HSMN NewsFeed) -- Sciton Inc. announced today that it will showcase the Sciton Pro-V(TM) 1319nm Nd:Yag laser for endovenous ablation of the great saphenous vein for the treatment of varicose veins at the International Vein Congress (IVC) held in Miami, Florida April 20-22.
Varicose veins are a common condition in the United States, affecting up to 60% of all Americans. Women, especially older women, are more likely than men to have this problem. Current treatment options include sclerotherapy, which involves injecting a solution into the vein, surgical removal of the varicose vein, or endovenous treatment with laser or electrical energy. Endovenous laser treatments are expected to triple in number over the next four years to reach over 300,000 by 2010.
In a recently completed study, Ronald G. Bush, M.D., FACS, of Dayton, Ohio, used the Sciton Pro-V endovenous system to treat the great saphenous vein of 30 patients. Each was successfully treated with no flow at day two as demonstrated through ultrasound. "The Pro-V is a very safe and effective system for treating saphenous insufficiency and compares favorably to other systems being used, and has the ability to treat the vein at lower treatment levels," stated Dr. Bush.
One of the unique benefits the Sciton Pro-V offers to physicians, is the ability to upgrade the system to a complete vein treatment center including a BBL(TM), broadband light source for vascular conditions such as telangiectasia and rosacea and, available in 2007, a ClearScan(TM) 1064nm Nd:Yag for the transcutaneous treatment of spider veins. With the introduction of the Sciton Pro-V, physicians are now able to address the complete vascular needs of their patients with one system. "Being able to add the BBL pulsed light to the Pro-V gives Sciton a clear advantage over other systems," stated Dr. Bush.
"The addition of the Pro-V to the Sciton product line expands the aesthetic applications of our broad and well-respected product line," stated Dale Koop, General Manager at Sciton. "We are committed to offering the most precise, innovative, and versatile lasers available. We are excited to show vascular surgeons and other vascular specialties, the value of the new Sciton Pro-V laser."
Sciton, located in Palo Alto, California, is committed to providing best- in-class laser and light source solutions for medical professionals who want superior durability, performance and value for applications that benefit their patients, their practice, and themselves. The MicroLaserPeel(TM) and Arctic(TM) peels are popular weekend procedures for facial rejuvenation giving patients a more youthful appearance and can only be offered with the Sciton PROFILE(TM) system. Other popular procedures offered by Sciton include hair removal, photo rejuvenation, wrinkle reduction, scar reduction and acne treatments. For more information and a complete listing of Sciton systems, log onto www.sciton.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.